Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct;23(10):1664-1670.
doi: 10.3201/eid2310.170724.

Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India

Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India

Madhu Chhanda Mohanty et al. Emerg Infect Dis. 2017 Oct.

Abstract

Prolonged excretion of poliovirus can occur in immunodeficient patients who receive oral polio vaccine, which may lead to propagation of highly divergent vaccine-derived polioviruses (VDPVs), posing a concern for global polio eradication. This study aimed to estimate the proportion of primary immunodeficient children with enterovirus infection and to identify the long-term polio/nonpolio enterovirus excreters in a tertiary care unit in Mumbai, India. During September 2014-April 2017, 151 patients received diagnoses of primary immunodeficiency (PID). We isolated 8 enteroviruses (3 polioviruses and 5 nonpolio enteroviruses) in cell culture of 105 fecal samples collected from 42 patients. Only 1 patient with severe combined immunodeficiency was identified as a long-term VDPV3 excreter (for 2 years after identification of infection). Our results show that the risk of enterovirus excretion among children in India with PID is low; however, systematic screening is necessary to identify long-term poliovirus excreters until the use of oral polio vaccine is stopped.

Keywords: India; Mumbai; OPV; VDPV; children; enterovirus; oral polio vaccine; poliovirus; primary immunodeficiency disorder; vaccine-derived polioviruses; viruses.

PubMed Disclaimer

Similar articles

Cited by

References

    1. World Health Organization. Progress towards global interruption of wild poliovirus transmission, January 2011–March 2012. Wkly Epidemiol Rec. 2012;87:195–200. - PubMed
    1. Sutter RW, Kew OM, Cochi S, Aylward B. Poliovirus vaccine—live. In: Plotkin, SA, Orenstein, W, Offit, PA, editors. Vaccines, 6th ed. Philadelphia: Elsevier; 2012. p. 598–645.
    1. Benyesh-Melnick M, Melnick JL, Rawls WE, Wimberly I, Oro JB, Ben-Porath E, et al. Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter. Am J Epidemiol. 1967;86:112–36. 10.1093/oxfordjournals.aje.a120717 - DOI - PubMed
    1. Chen RT, Hausinger S, Dajani AS, Hanfling M, Baughman AL, Pallansch MA, et al. Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States. JAMA. 1996;275:1639–45. 10.1001/jama.1996.03530450029028 - DOI - PubMed
    1. Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. 2015;35:696–726. - PMC - PubMed

MeSH terms

Substances